期刊文献+

腹膜透析小分子溶质清除评估研究进展 被引量:7

Advances in the evaluation of small molecule solute clearance in peritoneal dialysis
下载PDF
导出
摘要 小分子溶质清除是腹膜透析患者透析充分性评估的重要组成部分,本研究主要从其主要指标—尿素清除指数的定义、测定方法、与患者预后的相关研究及进展以及其可能的影响因素等方面进行阐述。尿素清除指数被认为与患者的体质量指数、性别、能量代谢率、种族等因素相关,其对腹膜透析患者预后的独立影响作用仍存在争议。在此基础上,本研究对尿素清除指数在腹膜透析小分子溶质清除评估中的作用及其局限性进行深入分析。 Small molecule solute clearance is an important parameter in the evaluation of dialysis adequacy of peritoneal dialysis(PD).Here we discuss its main evaluation indicator-Kt/Vurea,including its definition,measurement method,research and progress relating to patient's prognosis,and possible influencing factors.The value of Kt/Vurea is also related to patient's body mass index,gender,energy metabolism rate,ethnicity and other factors.It remains controversial that Kt/Vurea would independently affect the prognosis of PD patients.This review analyzes the role and limitation of Kt/Vurea in the assessment of small molecule solute clearance in PD.
作者 肖希 余学清 阳晓 XIAO Xi;YU Xueqing;YANG Xiao(Department of Nephrology,the First Affiliated Hospital,Sun Yat-sen University,Guangzhou 510080,China)
出处 《中国血液净化》 CSCD 2019年第4期217-219,共3页 Chinese Journal of Blood Purification
基金 国家自然科学基金(81774069 81570614) 国家重点研发计划项目(2016YFC0906100)
关键词 腹膜透析 透析充分性 尿素清除指数 Peritoneal dialysis Dialysis adequacy Kt/Vurea
  • 相关文献

参考文献1

二级参考文献16

  • 1[8]2000 Annual Report: ESRD Clinical Performance Measures Project. Am J Kidney Dis,2001,37 [Suppl 3] :S1 - S73
  • 2[9]Gokal R. Adequacy, nutrition and outcome in peritoneal dialysis: is there a link? Semin Dial, 1997,10:94-99
  • 3[10]Paniagua R, Amato D, Vonesh E, et al. For the Mexican Nephrology Collaborative Study Group. Effects of increased peritonea clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol, 2002, 13:1307- 20
  • 4[11]Lo, Wai-kei, Ho, Yiu-wing, Li, Chun-sang, et al: Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study. [ Miscollaneous Article ]. Kidney International, 2003,64(2) :649 - 656
  • 5[12]Lowrie EG, Teehan BP. Principles of prescribing dialysis therapy: implementing recommendations from the National Cooperative Dialysis Study. Kidney Int Suppl,1983, (13):S113- 22
  • 6[13]Teehan BP, Schleifer CR, Sigler MH, et al :A quantitative approach to the CAPD prescription. Peritoneal Dialysis Bulletin, 1985,152- 156
  • 7[14]Keshavish P:The solute removal index a unified basis for comparing disparate therapies. Petit Dial Int, 1995, 15:101 - 104
  • 8[15]Uribarri J. DOQI guideline for nutrition in long - term peritoneal dialysis patients: a dissenting view. Am J Kidney Dis, 2001, 37:1313 - 1318
  • 9[16]Twardowski ZJ. Individualized dialysis for CAPD patients. A review of the experience at the University of Missouri. Uremia Invest, 1984, 8:35-43
  • 10[1]Burkart J. Adequacy of peritoneal dialysis. In: Textbook of periotneal dialysis (2nd ed.), edited by Gokal R, Khanna R, Krediet R and Nolph K. Dordrecht. Klumer Academic Publishers, 2000, 435- 464

共引文献3

同被引文献58

引证文献7

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部